| Title: | Eli Lilly at Cowen and Company Health Care Conference Transcript |
| Price: | $54.00 |
| Publication Date: | Mar 17, 2008 |
| Source: | Thomson StreetEvents |
| Report Type: | Transcript |
| Abstract: | Final Transcript of LLY presentation, 17-Mar-08 2:30pm ET |
| Brief Excerpt: | ... - Cowen And Company - AnalystWell, good afternoon and welcome to the Eli Lilly session. We are very pleased to have with us Sidney Taurel, who is Chairman of the Board and CEO of Eli Lilly and Company. Sidney has positioned Lilly for a very exciting future with some of the industry's largest potential new products poised for regulatory news in ####. And indeed, when you stop and think about it, Prasugrel could be the industry's largest single new product opportunity. These products, of course, will be the engine of Lilly's growth over the next three to four years, which we characterize as solid up until the point of the Zyprexa patent expiration. Here to tell us more about Lilly's prospects is Sidney Taurel. And also, let me point out before I relinquish the mike to Sidney that the breakout starts at #:## in the Northeaster Room. So, you go out of this door and make a right. Thank you. ... |
| Word Count: | 5672 |
| Length: | 11 Pages |
| Ticker: | LLY |
| Time: | 2:30pm ET |
| Related Report(s): | |
| Format: | 
Adobe Acrobat
|
| Free Sample: |
Click
Here
to Download
|
Looking For Something Else?
